Cargando…
Tumor growth fueled by spurious senescence phenotypes
Cancer treatments can induce a form of senescence that halts cellular division while allowing continued secretion of tumor-promoting proteins. We recently found that antiangiogenic treatment resistance can lead to a transient hijacking of the senescence-controlled secretory machinery that, when ther...
Autores principales: | Mastri, Michalis, Ebos, John M. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512925/ https://www.ncbi.nlm.nih.gov/pubmed/31131302 http://dx.doi.org/10.1080/23723556.2019.1575707 |
Ejemplares similares
-
The senescence-associated secretory phenotype as a driver of tumor growth: does G3BP1 hold the key?
por: Omer, Amr, et al.
Publicado: (2021) -
HectH9 hijacks glucose metabolism to fuel tumor growth
por: Lee, Hong-Jen, et al.
Publicado: (2019) -
New control of the senescence barrier in breast cancer
por: Costa, Tânia D. F., et al.
Publicado: (2020) -
Cellular senescence enhances adaptive anticancer immunosurveillance
por: Marin, Ines, et al.
Publicado: (2022) -
Immunosurveillance of senescent cancer cells by natural killer cells
por: Iannello, Alexandre, et al.
Publicado: (2014)